Vaccinations

Why immunisation matters for healthy ageing

ILC is the UK’s leading authority on the impact of longevity on society, combining evidence, solutions and networks to make change happen. We hear...

Delta variant twice as likely to cause COVID hospitalisation

A Scottish study, published in The Lancet, found the Delta variant was twice as likely as the Alpha variant to cause COVID hospitalisation.

PHE study finds AstraZeneca vaccine 92% effective against Delta variant

Public Health England found that two doses of the Pfizer and AstraZeneca vaccine could still keep patients with the Delta variant out of hospital - but both are now less able to stop infection in the first place.

European Commission launches EU Digital COVID Certificate

Today (14 June) the Commission formally signed legislation to create the EU Digital COVID Certificate - which will be used for 12 months, beginning from 1 July, 2021.

Study finds Novavax 93.2% effective against Alpha variant

A new study found that the Novavax vaccine was 93.2% effective against the Alpha variant - with no clarification about vaccine performance against the Delta variant.

G7 leaders agree to donate 8% of necessary COVID vaccines

The G7 meetings produced a new donation of 870 million COVID vaccines to struggling countries, with no progress on a waiver for vaccine patents.

Scientists identify gene that could protect against severe COVID

A team at Newcastle University have identified a gene, HLA-DRB1*04:01, which could be responsible for individuals who are asymptomatic - suggesting that the gene offers some protection against severe COVID.

Scientists say vaccines less effective against Delta variant

According to a new study, the antibodies created by the Pfizer vaccine are on average less effective against the Delta variant.

MHRA approves Pfizer vaccine for 12-15-year-olds

The Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that the Pfizer/BioNTech COVID-19 vaccine is safe to use in 12-15-year-olds.

WHO gives emergency approval to Sinovac COVID-19 vaccine

The World Health Organisation (WHO) has given emergency approval to the Sinovac COVID-19 vaccine - because there is ongoing "access inequity" for countries in the Global South.

COVID-19 vaccines & genetic modification

Graham Brookes, Agricultural Economist with PG Economics, UK, charts how the development and deployment of COVID-19 vaccines, derived using techniques of genetic modification, highlight ideological inconsistency and hypocrisy.

UK approves use of single-dose Johnson & Johnson COVID vaccine

The UK today (28 May) approves use of the single-dose Johnson & Johnson vaccine that provides enough protection against the virus in one injection.

Scientists link AstraZeneca vaccine to arterial blood clots

Over the last three months, scientists have been tracing rare instances of blood clots in veins in connection to the AstraZeneca COVID vaccine - now, they have the first evidence of arterial blood clots, which can cause stroke.

What are the side effects of the Johnson & Johnson vaccine?

Here, we discuss some of the common misconceptions about side effects of the Johnson & Johnson COVID vaccine.

Digital tech in response to the COVID-19 pandemic

Justin Nogarede, FEPS Digital Policy Analyst, says that while digital tech can’t solve everything, can it solve anything? Read on to find out about the role of digital tech in the COVID-19 pandemic.

Moderna say COVID vaccine 100% effective in 12-17 year olds

The Moderna vaccine has been found to be 100% effective against COVID-19 in 12-17 year olds, according to new data from the TeenCOVE study.

PHE say one dose of vaccine 33.5% effective against Indian variant

Public Health England have found that both Pfizer and AstraZeneca vaccines against the Indian variant would have an efficacy of 33.5% in one dose.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders